Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma(J Exp Clin Cancer Res, (2018), 37, (49), 10.1186/s13046-018-0717-3)

Zhikui Liu; Yufeng Wang; Changwei Dou; Liankang Sun; Qing Li; Liang Wang; Qiuran Xu; Wei Yang; Qingguang Liu; Kangsheng Tu

doi:10.1186/s13046-022-02487-y

Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma(J Exp Clin Cancer Res, (2018), 37, (49), 10.1186/s13046-018-0717-3)

Zhikui Liu
, Yufeng Wang
, Changwei Dou
, Liankang Sun
, Qing Li
, Liang Wang
, Qiuran Xu
, Wei Yang
, Qingguang Liu
, Kangsheng Tu

The First Affiliated Hospital of Xi’an Jiaotong University
Zhejiang Provincial People's Hospital

科研成果: 期刊稿件 › 评论/辩论

摘要

This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-018-0717-3.

源语言	英语
文章编号	272
期刊	Journal of Experimental and Clinical Cancer Research
卷	41
期	1
DOI	https://doi.org/10.1186/s13046-022-02487-y
出版状态	已出版 - 12月 2022
已对外发布	是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

可持续发展目标 3 良好健康与福祉

访问文件

10.1186/s13046-022-02487-y

其它文件与链接

链接到 Scopus 的出版物

学术指纹

探究 'Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma(J Exp Clin Cancer Res, (2018), 37, (49), 10.1186/s13046-018-0717-3)' 的科研主题。它们共同构成独一无二的学术指纹。

引用此

Liu, Z., Wang, Y., Dou, C., Sun, L., Li, Q., Wang, L., Xu, Q., Yang, W., Liu, Q., & Tu, K. (2022). Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma(J Exp Clin Cancer Res, (2018), 37, (49), 10.1186/s13046-018-0717-3). Journal of Experimental and Clinical Cancer Research, 41(1), 文章 272. https://doi.org/10.1186/s13046-022-02487-y

@article{8608353c6a33486382a1012b8dac447c,

title = "Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma(J Exp Clin Cancer Res, (2018), 37, (49), 10.1186/s13046-018-0717-3)",

abstract = "This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-018-0717-3.",

author = "Zhikui Liu and Yufeng Wang and Changwei Dou and Liankang Sun and Qing Li and Liang Wang and Qiuran Xu and Wei Yang and Qingguang Liu and Kangsheng Tu",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = dec,

doi = "10.1186/s13046-022-02487-y",

language = "英语",

volume = "41",

journal = "Journal of Experimental and Clinical Cancer Research",

issn = "1756-9966",

publisher = "BioMed Central Ltd",

number = "1",

}

Liu, Z, Wang, Y, Dou, C, Sun, L, Li, Q, Wang, L, Xu, Q, Yang, W, Liu, Q & Tu, K 2022, 'Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma(J Exp Clin Cancer Res, (2018), 37, (49), 10.1186/s13046-018-0717-3)', Journal of Experimental and Clinical Cancer Research, 卷 41, 号码 1, 272. https://doi.org/10.1186/s13046-022-02487-y

Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma(J Exp Clin Cancer Res, (2018), 37, (49), 10.1186/s13046-018-0717-3). / Liu, Zhikui; Wang, Yufeng; Dou, Changwei 等.
在: Journal of Experimental and Clinical Cancer Research, 卷 41, 号码 1, 272, 12.2022.

科研成果: 期刊稿件 › 评论/辩论

TY - JOUR

T1 - Retraction Note

T2 - MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma(J Exp Clin Cancer Res, (2018), 37, (49), 10.1186/s13046-018-0717-3)

AU - Liu, Zhikui

AU - Wang, Yufeng

AU - Dou, Changwei

AU - Sun, Liankang

AU - Li, Qing

AU - Wang, Liang

AU - Xu, Qiuran

AU - Yang, Wei

AU - Liu, Qingguang

AU - Tu, Kangsheng

PY - 2022/12

Y1 - 2022/12

N2 - This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-018-0717-3.

AB - This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-018-0717-3.

UR - https://www.scopus.com/pages/publications/85137695066

U2 - 10.1186/s13046-022-02487-y

DO - 10.1186/s13046-022-02487-y

M3 - 评论/辩论

C2 - 36096795

AN - SCOPUS:85137695066

SN - 1756-9966

VL - 41

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

IS - 1

M1 - 272

ER -